HNSA Hansa Biopharma AB (publ)

4.451USD45.14 SEK · STO-4.61%Mkt Cap: 443.94M USDP/E: —

Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company…